# A Study of PF-04217903 in Patients With Advanced Cancer

> **NCT00706355** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** PF-04217903

## Key facts

- **NCT ID:** NCT00706355
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2012-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00706355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00706355, "A Study of PF-04217903 in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00706355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*